Category: Research

Month: 10 Sep 2009

Issue: not yet available

A new class of bio-markers for tracking anti-VEGF treatments

A novel finding of phosphorylated (activated) VEGF in vitreous samples may present a new class of biomarkers for the treatment and management of AMD and other retinal disorders.

Back to previous

Related News

Gearoid Tuohy


by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the December 3rd, 2018 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]